Skip to main content
NPJ Systems Biology and Applications logoLink to NPJ Systems Biology and Applications
. 2023 Nov 16;9:57. doi: 10.1038/s41540-023-00318-0

Modulating the dynamics of NFκB and PI3K enhances the ensemble-level TNFR1 signaling mediated apoptotic response

Shubhank Sherekar 1, Chaitra S Todankar 1, Ganesh A Viswanathan 1,
PMCID: PMC10654705  PMID: 37973854

Abstract

Cell-to-cell variability during TNFα stimulated Tumor Necrosis Factor Receptor 1 (TNFR1) signaling can lead to single-cell level pro-survival and apoptotic responses. This variability stems from the heterogeneity in signal flow through intracellular signaling entities that regulate the balance between these two phenotypes. Using systematic Boolean dynamic modeling of a TNFR1 signaling network, we demonstrate that the signal flow path variability can be modulated to enable cells favour apoptosis. We developed a computationally efficient approach “Boolean Modeling based Prediction of Steady-state probability of Phenotype Reachability (BM-ProSPR)” to accurately predict the network’s ability to settle into different phenotypes. Model analysis juxtaposed with the experimental observations revealed that NFκB and PI3K transient responses guide the XIAP behaviour to coordinate the crucial dynamic cross-talk between the pro-survival and apoptotic arms at the single-cell level. Model predicted the experimental observations that ~31% apoptosis increase can be achieved by arresting Comp1 – IKK* activity which regulates the NFκB and PI3K dynamics. Arresting Comp1 – IKK* activity causes signal flow path re-wiring towards apoptosis without significantly compromising NFκB levels, which govern adequate cell survival. Priming an ensemble of cancerous cells with inhibitors targeting the specific interaction involving Comp1 and IKK* prior to TNFα exposure could enable driving them towards apoptosis.

Subject terms: Dynamic networks, Stochastic modelling, Systems analysis, Numerical simulations

Introduction

Apoptotic response is a key outcome of Tumor Necrosis Factor Receptor 1 (TNFR1) signaling triggered by TNFα, a pleiotropic cytokine secreted by variety of immune cells in large quantities in several tissue microenvironment1. While normal cells maintain a balance between pro-survival and apoptotic phenotypic responses due to TNFα2,3, diseased ones such as those of certain cancer tissues favor proliferation by evading apoptosis and the strong host immune response4,5. However, counter-intuitively, certain tumors have higher sensitivity to apoptosis than the corresponding normal tissue6,7. Cells modulate the dynamic cross-talk between various intracellular entities wired in an underlying molecular machinery for maintaining this balance8. A detailed understanding of the causal mechanisms governing these dynamic cross-talks currently remains elusive, especially when inherent cell-to-cell variabilities leading to heterogeneous responses are present. Such an understanding is necessary to identify the targets for interventional therapeutic strategies for tilting the phenotypic balance towards cell-death without adversely affecting the otherwise normal functioning of an ensemble of cells. For instance, a population of malignant cells may be suitably primed to favor TNFR1 signaling mediated apoptotic outcome over a pro-survival response.

Activated NFκB is a key molecular player during TNFR1 signaling due to its ability to directly modulate both pro-survival and apoptotic responses912. NFκB regulates its own activity via different feedback loops involving IκB* and A20, both of which are transcribed by NFκB13,14. A20 not only regulates NFκB but also deubiquitinates RIPK1 and thereby favors apoptosis by curtailing signals to the necroptosis mode of cell-death15. On the contrary, pro-survival markers such as PI3K16, IKK*17, cIAP18, XIAP19, BCL – 220, directly or indirectly inhibit Caspase3, a precursor for cell-death21,22. Signal flow through a cell during TNFR1 mediated pro-survival and apoptotic responses is coordinated by the cross-talks between pathways involving these key regulators23. Thus, unravelling the causal mechanisms governing the dynamic signaling cross-talk between these pathways while accounting for cell-to-cell variability requires a detailed investigation of the signal flow through the TNFR1 signaling network.

Discrete model of TNFR1 network led to unveiling the checkpoints regulating apoptosis such as ubiquitination in membrane bound Complex – I, which consists of TRADD, RIPK1, TRAF, and cIAP1/222,24. Modulating this checkpoint by arresting the activity of TAK1, which mediates the interaction between IKK* and Complex – I, permits promoting apoptosis by downregulating the NFκB levels25,26 and regulating Compex–II, which consists of RIPK1, FADD, and Caspase827. These studies account only for population-averaged behavior and therefore cannot directly offer insights into the cell-to-cell variability driven dynamic cross-talk between pro-survival and apoptosis arms of the network.

Cell-to-cell variability causing an ensemble-level behavior can influence the signal flow through every cell in a population2831. The sources for variability during TNFR1 signaling range from protein abundances32 to cell-cycle effects33 to heterogeneity in pathway responses34. Besides, the correlation between the information exchanged during cross-talk across different signaling pathways can also contribute to the overall network variability35. Signaling networks usually have multiple pathways culminating in a phenotype. As a result, cells adopt different signal flow paths for committing to different cell-fates36. The sources for variability considered so far do not account for signal flow variability during TNFR1 signaling which is needed to mimic the natural heterogenous cellular response. Therefore, introducing signal flow variability while modeling single-cell level TNFR1 signaling response permits reliable identification of the governing principles behind the phenotypic heterogeneity.

Discrete modeling approaches such as Boolean Dynamic (BD) framework are amenable to study large-scale networks37. Petri-net25 and the multivalued Boolean model38 of TNFR1 signaling network revealed that regulation of NFκB by inhibition of Complex–I and of XIAP, respectively could modulate the cell-fate. The synchronous updating method of BD simulations employed in these studies are inherently deterministic in nature and therefore cannot account for heterogeneity in the phenotypic response, typically observed in an ensemble of cells39. Boolean model of TNFR1 network accounting for the inherent stochasticity using general asynchronous (GA) update scheme40 enabled distilling out the role of RIPK1 in cell-death41. GA scheme, though widely adopted for modeling signaling cross-talk in the presence of heterogeneous responses4143, can generate spurious signal flow paths of the network. Another promising approach is the probabilistic generalization of the BD modeling44,45. In these approaches, challenge lies in mimicking the Boolean functions by a continuous probability framework that hinges on the approximation of the logics44 and on network partitioning45, errors in which can result in severe information loss. An appropriate approach for quantifying a biological network’s phenotype reachability must therefore account for signal flow variability while minimizing spurious signaling paths, which can be achieved by using Random order asynchronous (ROA) update scheme based BD simulations.

The goal of this study is to unravel the causal mechanisms governing the dynamic cross-talk between pro-survival and apoptotic pathways that regulate the cell-to-cell signal flow variability guided TNFR1 signaling mediated heterogeneous cell-death response. In order to achieve this goal, we develop a Boolean dynamic (BD) model of a TNFR1 network that accounts for the cell-to-cell signal flow variability via the ROA updating scheme. We corroborate the model predictions with the experimental apoptotic phenotypic outcome exhibited by TNFα stimulated U937 and Jurkat-T cells, which respectively are pro-monocytic lymphoma and T-lymphocyte cell lines. We propose a Boolean Modeling based Prediction of Steady-state probability of Phenotype Reachability (BM-ProSPR) algorithm for systematic analysis of the BD model and also reliable quantitation of the network’s reachability to multiple phenotypes. We show that TAK1 inhibition can enable phenotype switching from pro-survival to apoptosis in the model cell lines considered. In particular, we show that, in the presence of cell-to-cell variability, TAK1 inhibition modulates the dynamic signaling cross-talk involving NFκB and XIAP to regulate apoptosis.

Results

TNFα induced ensemble-level apoptotic response

We consider TNFα driven ensemble-level apoptotic response in U937 and Jurkat-T model cell lines. We experimentally measured the steady-state percentage of cells resulting in apoptosis (Fig. 1) following exposure to 100 ng/ml TNFα (Methods and Supplementary Note 1.1). (The four-quadrant plots tracking different U937 and Jurkat-T cell states are in Supplementary Fig. 1.) While ~28% of the U937 population culminated in apoptosis, only ~13% of Jurkat-T cells exhibited cell-death (Fig. 1). Both U937 and Jurkat-T cells exhibited insignificant TNFα stimulated necrosis population (Supplementary Fig. 1, quadrant Q1)). Hence, unless otherwise stated explicitly, we restrict the definition of cell-death to apoptosis only. This indicates that the TNFα stimulation increases apoptosis but pro-survival response is dominant in both U937 (~72%) and Jurkat-T cells (~87%). This raises a question as to can these cells be primed to favor the ensemble-level apoptosis outcome in response to TNFα exposure and if so, what the targets are. Targets such as TAK127,46 and SMAC mimetics47 to enable population-averaged signaling leading to cell-death response have been identified in literature. However, whether these targets are likely to modulate the ensemble-level signaling to offer improved TNFα mediated apoptosis response remains unclear. Identifying the extent of apoptosis modulation these targets can offer while accounting for the ensemble-level behavior requires a detailed model analysis of the signal flow through the TNFα stimulated TNFR1 signaling network to pro-survival and cell-death phenotypes. Moreover, unravelling the cross-talks between the phenotypes in the presence of the cell-to-cell signal flow variability may enable finding mechanisms suitable for the ensemble-level response.

Fig. 1. Phenotype responses following TNFα stimulation.

Fig. 1

Steady-state TNFα mediated pro-survival and apoptosis responses in A U937 and B Jurkat-T cells for basal (no stimulation) and 100 ng/ml TNFα stimulation cases. The four-quadrant plot capturing different U937 and Jurkat-T cell states under these conditions are in Supplementary Fig. 1. Error bars represent mean ± standard deviation across three independent replicates.

We manually curated a molecular wiring diagram of TNFR1 signaling originating from TNFα and leading to apoptosis (Fig. 2)1,36,38,41,48. Fas Ligand (FasL), a TNF superfamily ligand, too leads to a strong apoptotic response via Fas receptor49. Since Fas mediated signaling shares majority of the death signal pathways in TNFR1 network, we considered apoptotic response originating from FasL as well for benchmarking purposes (Fig. 2). Note that since U937 and Jurkat-T cells show insignificant necrosis mode of cell-death, the corresponding signaling pathways were not included in the network. The signaling network consists of N = 40 entities and 62 causal interactions connecting them. (A detailed description of the network construction and the nature of the interactions along with a list of entities is in Supplementary Notes 1.2 and 1.3.) We classify these entities into 9 housekeeping (H), 2 input (I), 27 signaling (S) and 2 output (O) nodes (Supplementary Table 1). These 9 nodes classified as housekeeping nodes are constitutively present irrespective of any stimulation and also are present in abundance. Note that the levels of these nodes remain nearly constant under resting conditions in different mammalian tissues (Supplementary Table 1). Signaling nodes transduce signal flow from the input (TNFα or FasL) to output nodes (pro-survival represented by NFκB and Apoptosis).

Fig. 2. TNFR1 signaling network.

Fig. 2

Entities in pink, yellow, green and purple, respectively represent housekeeping, input, signaling and output nodes. Black arrows and red hammers capture the activation and inhibitory interactions. Detailed description of the network along with the node-specific Boolean functions are in Supplementary Notes 1.2 and 1.3.

Boolean Dynamic model of the TNFR1 signaling network permits stochastic phenotypic response

We quantify the inactive (OFF) or active (ON) forms of a node i by the Boolean variable vi=0or1, respectively. Note that vj=1jH. The network’s eventual response can be either apoptotic, pro-survival or anti-apoptotic phenotype depending upon the different combinations of the active/inactive form of the output nodes (Table 1). In Boolean dynamic (BD) framework, the logic of the causal interactions between the entities specifies the Boolean functions fi corresponding to a signaling/output node i37. For example, the Boolean function capturing the activation of entity c8* by c8*–DISC in the absence of FLIP or by c8*–Comp2 is specified by

fc8(v¯)=vc8Comp2|(vc8DISC&(vFLIP)) 1

where, set v®={vi,i} captures the instantaneous state of the network mimicking that of a cell. Note that in Eq. (1), &, | and ~, respectively represent AND, OR and NOT logic. While v® is in general an unordered set, for ease of representation and analysis, we place them in a specific order: 9H, 2I, 27S, 2O (Supplementary Table 1). Logic adopted for the interactions are incorporated in 29 node-specific Boolean functions corresponding to the signaling/output entities (Supplementary Note 1.3). Logic for every interaction was assigned based on the manually curated information pertaining to the underlying causality, details of which are in Supplementary Note 1.3.

Table 1.

Phenotypes permitted by the TNFR1 signaling network (Fig. 2) and the conditions that specify them.

Apoptosis
NFκB
Inactive (0) Active (1)
Inactive (0) Anti-apoptotic Apoptotic
Active (1) Pro-survival

Values inside a bracket indicate the Boolean value taken by the output nodes Apoptosis and NFκB.

We first reduce the dimensionality of the network using a partial-Logical steady state analysis (pLSSA)50 (Methods; Supplementary Note 1.4). For e.g., vTNFα=1 implies vTNFR1=vComp1=1 indicating that Comp1 value is fixed irrespective of the dynamics of the rest of the network (Supplementary Table 3). Under TNFα stimulation conditions, pLSSA led to fixing the Boolean values of 10 signaling nodes, viz., TNFR1, Comp1, Comp2, c8*–Comp2, Fas, DISC, c8*–DISC, c8*, cIAP1/2*, c3*–p20, and thereby resulting in N=19 dynamically varying signaling/output entities. Note that the value of these “fixed nodes” (listed in Supplementary Table 3) remains unchanged even if that of the remaining entities vary dynamically.

While several studies in literature have modeled TNFR1 signaling mediated cell-death using BD approaches10,25,38,41, these do not account for stochasticity caused by the cell-to-cell signal flow variability. We account for the cell-to-cell variability in signal flow by introducing the stochastic behavior due to interdependency of the nodes at all update steps via the random order asynchronous updating scheme, henceforth referred to as ROA40,51. Starting from a randomly chosen initial state v®0, we perform BD simulations of the network using ROA till a fixed-point attractor (FP) is reached and thereby track the corresponding signal flow path from v®0 to the FP37,40. (Note that in this study we only consider those absorbing states which are FPs.) Values of vApoptosis and vNFκB that specify the three phenotypes are in Table 1.

A directed one step state-transition between two consecutive states in a signal flow path is obtained by evaluating the Boolean functions of the dynamically varying entities. An input condition- and Boolean function-specific state transition graph (STG), whose state-space R consists of 2N states, is a collection of all directed signal flow paths to various FPs from any v®o. The choice of random sequence of Boolean function evaluation at every transition introduces the signal flow path variability to reach a FP from an initial state. Thus, reaching an FP via a signal flow path strongly hinges on the permutations that specify this random sequence at every state-transition involved (Methods).

TNFR1 network (Fig. 2) stimulated with TNFα can lead to only two FPs, viz., pro-survival FP v®FP1 = {9H}{2I}{27S}{2O}=1111111111011110001110101111100010111110 and apoptotic FP v®FP2= 1111111111011110001111010000011100000001 (Methods; Supplementary Note 2.1) where entities corresponding to those underlined digits are pLSSA-fixed. FPs for basal (no stimulation) and for FasL stimulation are in Supplementary Fig. 2. Starting from an initial state v®0 = 1111111111011110001110000000000000001100, chosen uniformly randomly, reaching either v®FP1 or v®FP2 depends upon the signal flow paths dictated by the chosen permutations (Fig. 3 and Supplementary Note 2.2). There could be several such signal flow paths leading to a certain FP from an initial state. Since the stochasticity in phenotypic response originates from signal flow path variability, knowledge of these will enable computing the absorption probability 𝓅FPv¯ with which the network would reach a FP starting from a state v®. The absorption probability p due to Markov-chain random walk on the state transition graph is computed by tracking all signal flow paths from an initial state to an attractor. Stimulation condition-specific steady-state probability PssFP1 of the TNFR1 network to settle into FP1 is given by

PssFP1=v¯iR𝓅FP1v¯iv¯iR1 2

Fig. 3. Signal flow paths to fixed points.

Fig. 3

Absorption of the initial state v®0 into two fixed points via distinct signal flow paths. The order in which the Boolean values of the entities are placed in a state is housekeeping (H), input (I), signaling (S) and output (O) nodes. Entities corresponding to the underlined values are pLSSA-fixed nodes. Blue arrows indicate one-step transitions with a certain permutation using ROA. Permutation used are in Supplementary Note 2.2.

Note that PssFP1 specifies the fraction of a population of cells exhibiting the phenotype FP1. Computing p requires reliable estimation of the state transition matrix (M) whose elements specify the transition probability between any two states in the STG given by

Mij=zijqmax=ziji,jzij 3

where, zij is the number of permutations causing the transition from state i to j, and qmax is the maximum possible permutations.

Quantifying M for TNFα stimulated pLSSA-fixed network (Fig. 2) consisting of N=19 dynamically varying entities demands 2N×N!×N (no. of states × no. of permutations/state × no. of Boolean function evaluations/permutation) = ~1.2 × 1024(Unless otherwise stated explicitly, henceforth, TNFR1 network refers to the pLSSA-fixed one.) Note that the number of function evaluations increases exponentially with N (Supplementary Fig. 3 and Supplementary Note 2.3). Moreover, every function in turn has embedded in it a complex set of Boolean operations dictated by the network wiring. Therefore, computing M even for a reasonably sized network is prohibitively expensive, in spite of the network dimensionality reduction. Approaches for computing M so far relied primarily on employing a smaller state space and arbitrarily chosen significantly smaller number of permutations52. Employing the entire state space only can offer reliable prediction of the absorption probabilities, and thereby the ability of the network to settle into a phenotype. Thus, there is a clear need for a BD modeling approach using ROA that considers all 2N states in the STG.

We posit that many chains of permutations could lead to identical signal flow paths, that is, those consisting of the same set of intermediate states in the STG constructed using all 2N states. We hypothesize that it is possible to judiciously consider only a certain randomly chosen fraction of maximum possible permutations qmax and yet compute a partial STG whose state transition matrix is equivalent to that of a complete STG. Note that the partial STG thus arrived will still contain all 2N states in the state space. In the next section, we develop and benchmark a systematic algorithm to identify the fraction of qmax that can reliably quantitate the (partial) state transition matrix M, dimensions of which being (2N,2N) and subsequently, implement it on TNFR1 network to unravel the effect of signal flow variability on phenotypic heterogeneity.

Boolean Modeling based Prediction of Steady-state probability of Phenotype Reachability (BM-ProSPR)

The goal of BM-ProSPR algorithm is to find PssFP of reaching different FPs by estimating a reliable state transition matrix M using a network-specific minimum number of permutations qlqmax. Flow chart capturing the systematic BM-ProSPR algorithm is in Fig. 4. We first specify the network of interest consisting of N nodes, the edges between the entities and the node-specific Boolean functions (Step 1, Fig. 4). (Note that the proposed algorithm can be used for networks with or without pLSSA-fixed nodes.) Next, starting with a null STG (S0) consisting of 2N isolated states and assuming an initial seed number of permutations q=q01, we construct a partial STG Sq0 (Step 2, Fig. 4). The steps involved in this construction are in Table 2. After constructing Sq0, the associated state transition matrix Mq0, where Mijq0=zijq0 is computed.

Fig. 4. Flow chart elucidating steps involved in BM-ProSPR.

Fig. 4

While T and PR, respectively represent Temporality and PageRank measures, D reflects the discordant PageRank fraction across successive permutations. Aq and Mq, respectively are the adjacency matrix and state transition matrix corresponding to the partial STG at the qth permutation. ϵ1 and ϵ2 are the error thresholds. PssFPi is the steady-state probability estimated using Mql at the required minimum number of permutations ql. ROA update scheme was used in the BD simulations.

Table 2.

Steps involved in the construction of partial STG (Sq) at the qth permutation.

Steps involved in constructing Sq
a) Choose a state v®iR.
b) Choose a permutation from qmax=N!.
c) Starting from v®i, for the chosen permutation, identify the state v®e reached after one BD simulation with ROA (Methods).
d) Update Sq with the one-step transitions between states v®i and v®e.
e) Repeat steps (b) to (d) for the remaining q-1 times while ensuring no redundancy in the permutation chosen in step (b) for a specific state v®i
f) Repeat steps (b) to (e) for all v®R.

Finding PssFP hinges on identifying the minimum number of permutations ql<qmax such that MqlMqmax, the state transition matrix of Sqmax. This implies that when q=ql the corresponding partial STG Sq must have sufficiently evolved to contain enough number of directed links such that Sq mimics Sqmax. We assess the extent of evolution of Sq by monitoring (i) the connectedness between a pair of states and (ii) the number of permutations causing one-step transitions between a pair of states (Step 3, Fig. 4). First, we consider connectedness by tracking the fractional increment in finding at least one directed link between a pair of states resulting from the update due to the qth permutation. We quantitate this fractional increment across permutation-driven STG snapshots using a temporality measure5355

Tq=1qk=1qi,j\inRaijk1aijki,j\inRaijk 4

where, aijk=1,ifatleastonelinkexistsbetweeniandjinSk0,otherwise and |.| represents mod. T is normalized and 0<Tq1,q, with limqqmaxTq0, indicating that the STG does not change any further. Next, we quantify the number of permutations leading to a transition between a pair of states by assessing the PageRank (PR)5658 of all v®R (Methods). (Details of the STG evolution quantified by these measures are presented in Supplementary Note 3.1) PR of all states in the null STG is 0. A comparison of the histogram of the PR of all v®Sq and of those in STG Sq+1 for the next permutation can, at best, indicate a change in the topology. However, it does not reveal how addition of a permutation led to a change, if any in the rank order of the states. We track change in this rank order by quantifying the discordance in PR following introduction of a new permutation.

We next introduce conditions on T and PR for identifying ql required to ensure sufficiency in the extent of evolution of the partial STG (Step 4, Fig. 4). We set ql required for this sufficiency and thereby, for MqlMqmax as that q which satisfies the conditions

TqTq1<ϵ1 5

and

Dq=1τq2=DqCq+Dq<ϵ2 6

where, τq=τq(PRq1,PRq) is the Kendall’s-Tau rank correlation59,60, and Dq and Cq, respectively capture the number of pairs having dissimilar and similar rank-order in PRq with respect to those in PRq1(Methods). Therefore, Cq+Dq=2N12N1 (Supplementary Note 3.2). Note that Dq (Eq. 6) specifies the fraction of pair of states having discordant PageRank across successive permutations. Thus, D offers a rational comparison of PR order achieved in successive permutations. We set the error thresholds ϵ1 and ϵ2 in Eqs. 5 and 6, respectively by identifying the value at which the absorption probability distribution saturates. Conditions in Eqs. 5 and 6, respectively ensure that the fractional increment of directed links in the STG and topological improvement achieved beyond ql are insignificant. For a certain q, if Eqs. 5 and 6 are not satisfied, we introduce additional permutation(s) and repeat Steps 2-4 (Fig. 4) until convergence is achieved. After identifying ql, in Step 5 (Fig. 4), we estimate the steady-state probability PssFPi (Eq. 2; Methods).

We systematically benchmarked BM-ProSPR using a 6-node apoptosis network of T-cell Large Granular Lymphocyte (T-LGL) cells42 permitting two phenotypes (FPs) (Supplementary Note 3.3) and an 8-node network regulating the spinal cord ventrilization in HEK293T61 permitting five phenotypes (Supplementary Note 3.4). Based on a sensitivity analysis, we assigned a value of 1×104 for both ϵ1 and ϵ2 for which the absorption probability distribution saturates. (Details of the sensitivity analysis used to identify the network-specific error threshold(s) along with an illustration are presented in Supplementary Note 3.5.) The computationally tractable complete STG for these two networks enabled validation of the predictions by BM-ProSPR. The minimum number of permutations required for construction of partial STG that results in accurate steady-state probability for reaching multiple phenotype are 286±65 and 167±2 for the 6-node and 8-node networks, respectively (Supplementary Note 3). Note that the number of permutations required is only a (small) fraction of the total number of possible sequences. In summary, we demonstrated that (a) temporality measure quantifies the extent of evolution of the STG better even in the absence of a complete one, which is typically the case for large networks and thereby making it amenable for analysis any biological system (Supplementary Note 3.3 and 3.4) and (b) BM-ProSPR accurately predicts the absorption probabilities and thereby the steady-state probability to reach multiple phenotypes.

NFκB and PI3K promote the TNFR1 signaling mediated pro-survival response during TNFα stimulation

We next decode the signal flow paths facilitating TNFα mediated apoptotic and pro-survival responses and analyze the transient signaling behavior. After setting housekeeping nodes active, vTNFα=1 and vFasL=0, we tracked the Boolean dynamics of the 19 dynamically varying entities of the TNFR1 signaling network (Fig. 2) using BM-ProSPR. (Note that 10 other signaling nodes attained pLSS (see fig. 3)). Only ql=219 (out of 19!=~1.2×1017) permutations were sufficient to construct the pSTG with 219=524288 states for the reliable estimation of the steady-state probability of reaching the pro-survival (v®FP1) and apoptotic (v®FP2) attractors (Fig. 3). (BM-ProSPR implementation, the evolution of the pSTG and associated details are discussed in Supplementary Note 4.1) An implementation of BM-ProSPR algorithm on a configuration model random network resulted in the minimum number of permutations for constructing pSTG similar to that obtained for the TNFR1 network (Supplementary Note 4.2). This suggests that the BM-ProSPR approach for construction pSTG could be extended to any network, in general. Since the pSTG corresponding to TNFα stimulation condition consists of only non-terminating strongly connected components (SCCs), TNFR1 network (Fig. 2) does not permit cyclic attractors40. Moreover, this pSTG is dominated by a single SCC consisting of ~18.9±0.2% states suggesting its importance in the network dynamics. A rational comparison of the pSTG phenotype reachability predictions with experimental measurements on U937 and Jurkat-T cell lines requires incorporation of cell line specific information into the BD model analysis. In these model cell lines, under resting conditions, NFκB is bound to IκB* 13,62. Thus, for the rest of this section, we consider only those signal flow paths in the pSTG that originate from 131072 states with vNFκB=0 and vIκB*=1.

The overall dynamical behavior of the TNFR1 signaling network (Fig. 2) is governed by the transient response of the nodes that it consists of. We consider the transient response of NFκB, IκB*, PI3K and c3*p17. While NFκB and c3*p17 are respectively direct regulators of the pro-survival and apoptosis phenotypes, PI3K modulates the signal flow to both NFκB and c3*p17. On the other hand, IκB* tightly controls the levels of NFκB. Deducing the transient response of the nodes in BD modeling using ROA is non-obvious. A signal flow path in the STG from a certain start state having the ability to reach both attractors mimics the transient behavior in a typical cell. We quantify the transient response of an entity and the embedded variability using an approach of tracking the variation of the node’s activity over the signal flow paths in the STG. An update step, that is, pseudo-time step, causing a one-step transition in the signal flow path qualitatively corresponds the real time. In a signal flow path, after every pseudo-time step, depending on the permutation considered, Boolean simulations force a node (say NFκB) to either transition between ON and OFF or maintain at ON/OFF level. Multiple signal flow paths connect a start state v®0 and the two attractors FP1 and FP2. At a certain pseudo-time step t, the conditional probability ENFκBtv®0 of node NFκB to either transition to an active form or remain activated in these multiple signal flow paths (from v®0) indicates the extent of instantaneous participation of NFκB in the signaling process in a cell with the initial condition v®0. Thus, ENFκBtv®0 over all the pseudo-time steps mimics the transient activity of NFκB measured experimentally in a single-cell exposed to TNFα. We define this conditional probability of finding NFκB being active at an update step t as the fractional overall number of permutations (in the tth step) across all signal flow paths wherein the associated one-step transitions either cause an activation of NFκB or maintain it activated. A collection of the pseudo-time step varying conditional probability over all start states in the STG qualitatively captures the ensemble-level NFκB dynamics in a BD framework. Details of the procedure adopted for computing the ensemble-level dynamics of a node and an illustration of the same are respectively in Methods and Supplementary Note 4.3.

We next compare the BD modeling predicted dynamics of the conditional probability of certain nodes such as NFκB, IκB*, PI3K and c3*p17 being active (Fig. 5A–D) contrasted with corresponding experimental observations (Fig. 5E–H) reported in literature in U937 or equivalent cell lines8,63. Even though the update step and the sampling times are not directly comparable, we align the pseudo-time of the BD simulations by contrasting the undulations in the ensemble-averaged ENFκBt trajectory with that reported in experimentally measured NFκB transients. We then fixed this update step and real-time mapping for the dynamics of the entities considered. We then juxtapose the model predicted ensemble-level dynamics and the experimentally measured population-averaged transients for NFκB, IκB*, PI3K and c3*p17 in Fig. 5 to contrast the nature of undulations, phase-lag and the steady-state levels. Note that cloud (Fig. 5A–D, pink) around the population-averaged transients (Fig. 5A–D, red) encompasses the dynamics from individual start states of the STG. Comparison of the representative model predicted transients (Fig. 5A–D dashed blue) with the experimentally measured dynamics (Fig. 5E–H) showed that the model predicted the number of crests and troughs exhibited in the NFκB transients. The model simulated ensemble-averaged IκB* transient compared with that of NFκB clearly shows these two are out-of-phase with each other (Fig. 5A,B), as observed in the experimental population-averaged measurements (Fig. 5E,F). While the model predicts that both NFκB and IκB* settle to higher and lower levels, respectively at the fourth pseudo-time point, measurements show this trend only for NFκB. The discrepancy between the model predicted and experimental measurements of IκB* transients could be attributed to the inability to account for the strong temporal kinetic control present in the cells in the BD framework. The stimulated TNFR1 network may have a higher chance of favoring a pro-survival response in the initial phase (<3) owing to high probability of NFκB being active (Fig. 5A) along with PI3K concomitantly showing an increasing trend after the first step (Fig. 5C). (Note that PI3K levels in the very early phase (1st pseudo-time point) decreases rapidly as compared to experimental observations. This can be reconciled by considering those states having NFκB=1 (see Supplementary Fig. 13B).) In the initial phase, the negative regulators of NFκB could be response for the probability of finding NFκB being active in the individual trajectories to hover around the ensemble-average indicating moderate cell-to-cell variability. On the contrary, PI3K permits wider range for the cell-to-cell signal flow variability in the early phase. Moreover, in the early phase, a large cell-to-cell variation present in c3*p17 transients indicates that some start states may drive the network towards apoptosis (Fig. 5D). However, eventually, in the late-phase (>6 timesteps) probability that NFκB will be active settles down to ~0.64 for all start states considered (Fig. 5A). This indicates that major fraction (~64%) of the signal flow paths from various start states are likely to favor pro-survival response, which requires NFκB to remain active. Concomitantly the probability of c3*p17 being active decreases to <0.5 in the late-phase indicating that TNFα stimulation is unlikely to result in a strong apoptotic response (Fig. 5D). Transients of PI3K and c3*p17 are out of phase in the very early phase (1st update step). On the contrary, in the late-phase Ec3*p17(t) being in-sync with EPI3K(t) suggests that the fraction of cells taking apoptotic phenotype maybe regulated by PI3K via Bax (Fig. 5C,D). The decision to attain a phenotypic response is made due to changes in activity of nodes in the initial phase.

Fig. 5. Ensemble level dynamics of key intracellular signaling entities.

Fig. 5

Model-predicted transients of the conditional probability A ENFκB, B EIκB*, C EPI3K and D Ec3*p17, respectively of the nodes NFκB, IκB*, PI3K, and c3*p17 being active at an ensemble-level (Methods). Cloud around the population-averaged response (red) captures the range for different transients achieved from various start states of the STG that are capable of reaching both phenotypes. Dynamics of E NFκB, F IκB*, G PI3K/AKT and (H) caspase-3. While NFκB transients are in mouse fibroblast cells treated with TNFα 63, those of PI3K/AKT and Caspase3 are in TNFα stimulated U937 cells8. Note that response of c3*p17 in the network mimics that of Caspase3 in a cell. The update steps in the Boolean simulations are equated to the experimental sampling time by qualitatively aligning the undulations in NFκB transients. Blue dashed line captures the trajectory from a randomly chosen start state. For each of the model cases in (A) to (D), trajectories having the same trend as measurements are presented in Supplementary Fig. 13 in the form of a cloud.

In order to assess the extent to which TNFα mediated pro-survival response is orchestrated by the TNFR1 network (Fig. 2), we computed 𝓅FP1v¯=1𝓅FP2v¯v¯R (Methods). Distribution of 𝓅FP1v¯ shows that only 3.125% of the states belonged only to the apoptosis basin of attraction BFP2 and clearly indicates that a pro-survival response is favoured (Fig. 6). Moreover, there are no states exclusively favoring the pro-survival response. (Note that pro-survival response is favored under no stimulation (basal) conditions as well (Supplementary Fig. 14).) The steady-state probability PssFP2=1PssFP1 (Eq. 2) of the network reaching apoptosis attractor under TNFα stimulation and basal conditions respectively are ~0.34 and ~0.04. Note that this trend of pro-survival response being a dominant response is in line with the phenotypic observations for U937 and Jurkat-T cells (Fig. 1). This shows that the dynamics of NFκB, PI3K and c3*p17 being active (Fig. 5) clearly reflects the pro-survival response being the dominant outcome of the TNFα stimulated TNFR1 network.

Fig. 6. Absorption probability distribution.

Fig. 6

Histogram of the fraction of states reaching pro-survival FP (FP1) with a certain absorption probability 𝓅FP1v¯.

In summary, NFκB, PI3K and c3*p17 transients extracted from the Boolean dynamics contain strong signatures of the TNFα stimulated TNFR1 network favoring pro-survival phenotype over cell-death at the single-cell level. This leads to a question as to what governs a cell to favor TNFR1 signaling mediated pro-survival phenotype. Further, can the signal flow through pro-survival pathways and specifically those involving NFκB be modulated to enable phenotype switching from pro-survival to apoptosis at the single-cell level?

Comp1-IKK* activity reduction enables pro-survival to apoptosis phenotype switching

Modulation of the signal flow through a pathway can be achieved by either suppressing the activity of a node or the action of an important interaction in such a manner that it does not hamper the otherwise normal functioning of the network. We identify such a target by analyzing the signal flow paths in the pSTG consisting of all the 524288(=219) states. We enumerated the frequency of occurrence of a Boolean value (0 or 1) taken by nodes in the 4096 states that exclusively belonged to BFP2. In all these states, Boolean value of 7 nodes, viz., Comp1IKK*, IκB*, IKK*, PI3K, NFκB, Raf1 and BCL-2 (Table 3A), which are locked in nested loops (Fig. 7A), were the same. Note that the locking of Boolean values of these subset of nodes occurs only in ~0.8% of states. This suggests the strong presence of cell-to-cell signal flow variability while starting from a significant number of states in the STG. Signal flow towards apoptosis phenotype necessitates arresting of NFκB along with other 5 nodes as it inhibits cell-death via multiple pathways such as those involving BCL-2, XIAP, FLIP (Fig. 2). IκB* accumulates in the absence of BCL-2 which prevents NFκB activity (as noted in Supplementary Note 1.2). Absence of active PI3K and Raf1 results in lack of activation of IKK*, and therefore the inhibitory action on IκB* is absent6466, and thereby preventing NFκB activation causing arrest of signal flow towards pro-survival phenotype (Fig. 1)67,68. However, the states having all Boolean value combinations for these seven nodes other than that specified in Table 3A will belong either exclusively to pro-survival basin of attraction BFP2 or to both BFP1 and BFP2. States with 16 (=24) out of the 127 other combinations of the values of these 7 key nodes belong exclusively to the BFP1 (Table 3B). (Note that the remaining 111 combinations have 0<pFP1=(1pFP2)<1.) In all these 16 states, IκB* takes an inactive form and thereby permitting activation of NFκB leading to pro-survival response. Since inhibitory action on IκB* is via either IKK* or Comp1IKK* or BCL-2 (Fig. 2), BCL-2 taking a Boolean value of 1 (active) along with active NFκB is sufficient to maintain a pro-survival response (Fig. 2). But, modulating BCL-2 alone may not shift the signal towards apoptosis. States belonging exclusively to BFP1 can therefore have either active or inactive Comp1IKK*. Thus, these 7 nodes locked in the nested loop regulate the cross-talk signaling between the pro-survival and apoptotic responses in the presence of cell-to-cell signal flow variability. We therefore ask a question if tweaking of this nested loop increases the chances of TNFα mediated apoptosis in a heterogeneous cell population. This requires modulation in signal flow inside this loop that could enable switching of phenotype, specifically from pro-survival to apoptotic response.

Table 3.

Combination of Boolean values taken by the 7 key nodes in the states that belong exclusively to either (A) apoptosis or (B) pro-survival attractors.

Comp1IKK* IκB* IKK* PI3K NFκB Raf1 BCL2
Apoptosis attractor (FP2)
0 1 0 0 0 0 0
Pro-survival attractor (FP1)
X 0 X X 1 X 1

Note that X refers to the value being either 0 or 1.

Fig. 7. Phenotype switching from pro-survival to apoptosis.

Fig. 7

A Nested loop formed by the 7 key nodes regulating the signaling cross-talk to TNFR1 signaling mediated apoptosis response in the presence of cell-to-cell signal flow variability. Note that IKK (pink box) is a housekeeping node and Comp1 is pLSSA-fixed node. B A comparison of model predicted and experimentally measured apoptosis fold change obtained under TAK1 inhibitory conditions. While this inhibitory action in U937 and Jurkat-T cells was achieved using EDHS-206 chemical inhibitor (Methods), correspondingly Comp1IKK* inactivation in the model simulations mimicked TAK1 inhibition. Error bar in the model case captures mean ± standard deviation across 50 STG reconstructions. Error bars in cell line cases capture mean ± standard deviation across three independent replicates. C Cumulative distribution of the fraction of states with difference in the absorption probability (Δp) in the presence and absence of Comp1IKK*. Note that the errorbars on the distribution capture the standard deviation over 50 STG reconstructions. Signal flow paths from those states with vNFκB=0 and vIκB*=1 were considered to estimate F (Model) and Δp in B and C, respectively.

Switching of pro-survival to apoptotic phenotype can be enabled by either (i) shifting an initial state exclusively in the BFP1 to BFP2 or (ii) increasing the absorption probability of an initial state to a desired FP. While the former will require simultaneous fixing of the Boolean values of the 7 cross-talk regulating nodes (Table 3A), the latter can be achieved by modulating a single entity. Since tweaking multiple nodes simultaneously could be detrimental especially shutting down NFκB completely, we consider increasing the absorption probability.

We analyzed the signal flow paths culminating into FP2 and identified that knocking-off Comp1IKK* could facilitate tilting the cell-fate towards apoptosis (Supplementary Note 4.6). Since Comp1IKK* formation is mediated by TAK169,70, signal flow through this complex can be modulated by inhibiting TAK1. Use of TAK1 inhibition to promote TNFα mediated apoptosis has been demonstrated previously under population-averaged measurements46. Moreover, TAK1 inhibition can promote apoptosis either by reducing NFκB activity71 or by regulating signaling through RIPK1-FADD-Caspase8 pathway27. Since necrotic mode of cell-death seldom occurs in the cell lines considered (Fig. 1 and Supplementary Fig. 1), as noted in earlier section, arresting signal flow through RIPK1-FADD-Caspase8 pathway to promote apoptosis is highly unlikely. Therefore, the NFκB dependent mechanism of promoting TNFα mediated cell-death under TAK1 inhibition is in action in Jurkat-T and U937 cells. While these studies have considered population-averaged level approaches, what will be the extent to which modulation of the cross-talk can enable a shift in the TNFα mediated apoptosis response, in the presence of cell-to-cell signal flow variability, remains unclear.

In order to unravel this, we created a perturbed TNFR1 network (henceforth referred to as TNFR1Δ) wherein Comp1IKK* node is turned-off by setting fComp1IKK*=0 throughout the simulations. BM-ProSPR implemented on TNFα stimulated TNFR1Δ (Supplementary Note 4.1) predicted that the steady-state probability of reaching apoptosis attractor is 0.44. (Note that setting fComp1IKK*=0 will halve the number of states with NFκB=0 and IκB*=1 to 65536). In order to validate this prediction, we experimentally measured the apoptosis fraction in U937 and Jurkat-T cells pre-treated with EDHS-20669, an inhibitor of TAK1 and subsequently exposed to 100ng/ml TNFα (Methods; Supplementary Note 4.7). Pre-treatment with TAK1 inhibitor for 1 h causes a significant reduction in the Comp1IKK* activity69. Note that both Jurkat-T and U937 cells treated with EDHS-206 for extended duration exhibited same viability as that observed for the basal (unstimulated) case (Supplementary Note 4.7). In order to contrast the model predictions with the experimental measurements, we define a fold-change F quantifying the effect of the Comp1IKK* perturbation on apoptosis reachability given by

F=PssFP2TNFR1ΔPssFP2basalPssFP2TNFR1PssFP2basal=%ApoptosisTNFR1Δ%Apoptosisbasal%ApoptosisTNFR1%Apoptosisbasal 7

where, PssFP2TNFR1Δ and PssFP2TNFR1 respectively are the steady-state probabilities of reaching cell-death by TNFα stimulated TNFR1Δ and TNFR1 networks. PssFP2basal is the steady-state probability of the unstimulated TNFR1 network to reach FP2. Fold-change F computed using the model simulations and estimated from experimental observations for both Jurkat-T and U937 cells are contrasted in Fig. 7B. The BD model of TNFR1Δ was able to predict the fold-change reflecting the increased apoptotic response exhibited by both Jurkat-T and U937 cells under reduced Comp1IKK* activity. This shows that inhibiting TAK1 is a promising strategy to tilt the phenotypic response from pro-survival to apoptosis in the presence of cell-to-cell signal flow variability as well. We reason that this predictive ability is due to the effect of Comp1IKK* perturbation on the absorption probabilities, as captured by the Δ𝓅=𝓅FP2v¯(TNFR1Δ)𝓅FP2v¯(TNFR1) (Fig. 7C). Lack of the activity of Comp1IKK* has resulted in ~88% of the states exhibiting increased ability to settle into apoptosis (Fig. 7C), while the Δp=0 for the remaining states. Notably, on an average, ~20% of the states showed greater than 10% increase in the probability of settling into apoptosis.

An increase in the ability of a state to settle into apoptosis attractor in TNFR1Δ is due to the re-wiring of the dynamic path taken by it to reach the attractor, resulting in a shift in the signal flow paths. An illustration of the signal flow path alteration caused by the perturbation is in Supplementary Note 4.6. Such shifts will occur at several one-step transitions in the STG. This can be tracked by following the effect of shutdown of Comp1IKK* on the Boolean dynamics of the key signaling nodes that enable cross-talk between the pro-survival and apoptosis arms of TNFR1 network. For this purpose, we randomly chose a STG reconstruction for the TNFα stimulated TNFR1Δ in which 8282 states exhibited more than 10% increase in absorption probability to reach apoptosis FP. Using these as the start states, we estimated ΔEt=(ETNFR1ΔtETNFR1t)/ETNFR1t) for NFκB, IκB*, BCL-2, XIAP, Bax and c3*p17 being active following shutdown of Comp1IKK* activity. Inhibition of Comp1IKK* leads to, on an average a ~14% increase in the ability to find IκB* being active (Fig. 8B, inset). Concomitantly, in the late-phase, the average relative change in the dynamics of NFκB being active is ~3% but with a large cloud around in the early phase (Fig. 8A). This suggests that the perturbation causes only a small fraction of the signal flow path, on an average, involving NFκB to be shutdown. Thus, the other signaling pathways being active could ensure the other normal functioning of the cell to be preserved intact.

Fig. 8. Effect of Comp1 – IKK* inhibition on intracellular signaling entities.

Fig. 8

Relative change of the transients of A NFκB, B IκB*, C Bax, D XIAP and D c3*p17 being active for the case of TNFR1 network with inactive Comp1IKK*. Relative change is quantified by ΔE(t)=ETNFR1ΔtETNFR1t)/ETNFR1t. Pink cloud around the population-averaged trajectory (red) encompasses the ΔE from different start states. Blue dashed line captures the trajectory for each of the nodes from the same randomly chosen start state. Inset in B captures the zoomed version of a part of the figure for better clarity.

Large cloud around ΔENFκB in the early phase (t<2) indicates that for those start states for which ΔENFκB<0, the signal flows paths having NFκB being active in the case of TAK1 inhibition has significantly reduced compared to that without inhibition. These signal flow paths are perhaps diverted to apoptosis attractor leading to an increased absorption probability. This diversion to apoptotic signaling is mediated primarily by Bax and XIAP. While NFκB directly activates XIAP, it indirectly inhibits Bax via two pathways, which respectively involves BCL-xL and BAD-14-3-3 (Fig. 2). This indirect inhibition could cause the start states having ΔENFκB<0 to exhibit ΔEBax>0 as witnessed by the large cloud above the mean ΔEBax in the early phase (Fig. 8C). Since XIAP is activated by NFκB, cloud around mean ΔEXIAP in the early phase is similar to that of ΔENFκB. On the other hand, while Bax can cause an increase in apoptosis by exhibiting a positive influence on c3*p17, XIAP indirectly reduces cell-death response by inhibiting c3*p17 in multiple ways including a pathway from Bax via c3*p20 (Fig. 2). Therefore the cloud around c3*p17 exhibits a larger relative change for a prolonged time (up to 4th timepoint), indicating significant rewiring of the signal flow paths originating from many start states and leading to c3*p17 being active, and thereby improving the ability for those states to reach apoptosis. This shows that XIAP could be the prime mediator of the cross-talk between the pro-survival and apoptosis pathways. In fact, this finding is substantiated by the experimental evidence that TAK1 inhibition downregulates XIAP levels in multiple TNFα stimulated cells18,72,73.

In summary, we show that reduction in the activity of Comp1IKK* can improve the ability of cells to favor apoptotic response over pro-survival phenotype, in the presence of cell-to-cell signal flow variability. The model incorporating the inhibition of Comp1IKK* predicts the apoptotic phenotypic response in Jurkat-T and U937 cells pre-treated with TAK1 inhibitor, which induced the inhibitory conditions. In particular, the reduction in the activity led to modulation of the ensemble-level XIAP mediated dynamic cross-talk between the pro-survival and apoptotic arms of the TNFR1 network to tilt the phenotype towards cell-death.

Discussion

Dynamic cross-talk regulating the TNFR1 signaling mediated pro-survival and apoptotic phenotypic responses due to TNFα stimulation is well-known2. Since TNFα cytokine is secreted in large quantities by immune cells in a tumor microenvironment74, varying extent of dynamic TNFR1 signaling is continuously occurring in a population of cancer cells. Therefore, this dynamic cross-talk regulation during TNFR1 signaling at a single-cell level can be capitalized upon for various cancer therapeutic purposes7,75,76. In this study, using a Boolean dynamic model accounting for cell-to-cell signal flow variability juxtaposed with experimental measurements, we demonstrate that NFκB along with BCL-2 and PI3K via XIAP regulates the dynamic cross-talk signaling between TNFR1 network mediated pro-survival and apoptotic responses. The sources for heterogeneity are the variation in the active/inactive state of different nodes and in the multitude of transient signal flow paths, introduced by the random order asynchronous update scheme. We distilled out the dynamic regulation via this cross-talk by systematically analyzing the partial state transition graph (pSTG), constructed using a computationally effective algorithm: ‘Boolean Modeling based Prediction of Steady-state probability of Phenotype Reachability’ (BM-ProSPR). Model analysis predicted the phenotype switching from pro-survival to apoptosis in U937 and Jurkat-T cell lines induced by TAK1 inhibition.

TNFα activated TNFR1 network model predicts the experimentally observed trend in Jurkat-T and U937 cells that pro-survival response is the favorable outcome under normal conditions. We showed that the transient variation of the key intracellular entities NFκB, IκB*, PI3K, and c3*p17 being active follows the experimentally observed trend of the corresponding population-averaged trajectories reported in literature8,63. This demonstrates that the model developed could mimic the ensemble-level dynamics of the intracellular machinery and therefore captures the phenotypic response. A simultaneous regulation of NFκB, PI3K, and BCL-2 dynamics by blocking the Comp1IKK* complex can lead to a partial shift of the phenotypic response from pro-survival to apoptosis at single-cell level. This shift can be achieved by preserving many signal flow paths resulting in NFκB being active, especially at the late-phase suggesting the pro-survival signals continue to be preserved to some extent, indicating that essential functions may not have been sacrificed. We substantiated the phenotypic switching using single-cell level experimental measurements in the model cell lines pre-treated with TAK1 inhibitor, a direct modulator69 of Comp1 and IKK* complex formation yet preserves the dynamics of essential nodes. TAK1 inhibition favoring the TNFα mediated apoptosis response via NFκB has been shown previously46. However, we show that TAK1 inhibition additionally modulates the dynamic cross-talk between the TNFα mediated pro-survival and apoptotic pathways even when heterogeneity in the signal flow paths are present. A partial switch in the phenotype switching could perhaps be due to the inability of TAK1 inhibitor to shutdown other non-canonical pathways activating NFκB77,78. While our analysis show only partial shift to apoptosis, a possible approach to enable a significant phenotype switching from pro-survival to apoptotic response is to inhibit LUBAC, which by directly regulating IKK* arrests NFκB activity7982. Although this could be a promising approach, a complete shutdown of NFκB may be undesirable as it can significantly affect the other important and necessary functions of a cell.

A signal flow path from a start state, extracted from the BM-ProSPR constructed pSTG by computing the connectivity (C) and signal flow path (P) matrices (Methods), mimics the dynamics of a typical TNFα stimulated cell. For unperturbed conditions, simulated transients (of a few nodes) from ~48% of the start states were qualitatively similar to those measured (Supplementary Fig. 13A). Thus, the multitude of signal flow paths originating from such a start state could guide in assimilating the ensemble-level dynamic trends of the signaling nodes in TNFR1 network that either were not or could not be measured experimentally. A comparison of these trends with those computed under other perturbed conditions could offer insights into how signal flow paths can be suitably re-wired for enabling improved phenotype modulation following TNFα stimulation without compromising essential cellular functions.

BM-ProSPR employs Temporality55 and PageRank57 measures to self-learn the extent of evolution of the STG and thereby, aids in identifying the minimum number of permutations required to capture adequate signal flow paths, and the associated variabilities. For small, medium and large networks considered, BM-ProSPR predicted that a (tiny) fraction of the maximum possible permutations is sufficient for constructing a reliable pSTG (Supplementary Figs 6, 7, and 11). For example, only 219 out of 19!(=~1.2×1017) permutations are sufficient to reliably quantify the TNFα activated TNFR1 network’s reachability to pro-survival and apoptotic phenotypes (Supplementary Fig. 14). The self-learning nature of BM-ProSPR and the ensuing significantly low computational cost makes it directly amenable to larger networks for which constructing a complete STG is infeasible. Thus, BM-ProSPR makes performing signal flow analysis and thereby distilling out causalities in large biological networks feasible. BM-ProSPR’s ability to reliably construct partial STG for a random configuration model with pre-decided degree, sign and logic distributions suggests that developed algorithm can be applied to study any curated network to model, even non-biological systems. While BM-ProSPR assumes an ON/OFF behavior for a node, the approach can be extended to track cell-to-cell signal flow variability when the entities are multi-valued83 causing a steep increase in the state space size.

The ability of BM-ProSPR implementation hinges on starting with a null set consisting of all the states permitted by the Boolean model of the network. Very large biological networks, even after discounting for the partial logical steady-state fixed entities, can have significantly large state space. For such networks, BM-ProSPR too can offer a computational challenge in performing the signal flow analysis. Arriving at strategies for identifying a threshold minimum number of states needed for the reliable construction of the pSTG underlying such very large biological networks could help circumvent this challenge.

Methods

Cell culture and reagents

U937 and Jurkat-T cells were procured from the Cell Repository at National Centre for Cell Science (NCCS), Pune, India. It was cultured in RPMI-1640, supplemented with 10% fetal bovine serum (FBS), 2 mmol/l L-glutamine, and 1% antibiotic solution, all procured from HiMedia (Mumbai, India) with a cell-seeding density of 5 × 105 cells/ml. Cells were maintained at 37 °C in a humidified 5% CO2 incubator. 17.3 kDa TNFα (GenScript) was reconstituted in double-distilled water to a concentration of 100 μg/ml.

Apoptosis detection by Annexin V/PI staining

U937 and Jurkat-T cells were stimulated with 100 ng/ml TNFα for the specified time under the standard incubating conditions. Cells were then harvested in the form of a pellet by centrifugation at 1000 rpm for 5 min at room temperature (RT). Harvested cells were resuspended in 1X Annexin binding buffer, and then stained with FITC-labeled Annexin V and PI dyes (BD Pharmingen, San Diego, CA, US). The fluorescence from the bound Annexin V and PI were detected using BD FACS Aria (BD Biosciences, San Jose, CA, US) within 30 min of dye addition.

One-step state transition using ROA

Starting from a state v®, using a unique permutation sequence q chosen uniformly randomly, the first node, say i, in q is updated by evaluating the corresponding Boolean function fi(v®) to arrive at an intermediate state v®i. The next node j in q is updated by evaluating fj(v®i) to obtain v®j. This procedure of finding the intermediate states is repeated until all nodes in q are exhausted. The final state thus achieved is the one that is a result of the one-step state transition originating from v® and corresponding to q.

Partial logical steady-state analysis (pLSSA)

The network’s list of interactions with the associated logic were parsed into CellNetAnalyzer (CNA)50. Housekeeping and the (relevant) input nodes were set to ‘1’. “Compute logical steady-state” option in CNA was used to identify the nodes attaining partial Logical Steady-State (pLSS) and the corresponding Boolean value.

Identification of fixed points

Starting from each of the 2N states R, a one-step transition was computed using any one permutation, chosen uniformly randomly. The state for which the one-step transition using the chosen permutation results in the same state is the fixed point. Detailed procedure along with an illustration is provided in Supplementary Note 2.1.

PageRank

PageRank vector PRq corresponding to Mq after the qth permutation was estimated by solving PRq=αMqPRq+1αeT, where, α=0.85 and eT is a one vector. PRq after every q was computed using the inner-outer iterative scheme57.

Kendall’s-Tau rank correlation

The elements of PRq were re-sorted in the same order of placement of the states in PRq1, that is, PageRank order after the penultimate permutation. Kendall’s-Tau rank correlation τq(PRq1,PRq) was computed by comparing the rank of the states in PRq and PRq1, and subsequently enumerating the concordant and discordant pairs. A SciPy implementation scipy.stats.kendalltau, accessed from Matlab R2018b®, was used for this purpose84.

Markov chain random walk approach for estimating Absorption probability

The state transition matrix Mql was re-arranged into a canonical form I0RQ where, I and 0, respectively are (n×n) identity matrix denoting self-loops for FPs and (n×(2Nn)) zero matrix with n being the number of FPs in the STG. While matrix R specifies the transition probability of states transitioning directly into a FP, Q captures that into any other transient state. Absorption probability 𝓅FPiv¯ to reach an attractor FPi from any transient state v® due to Markov chain random walk on the STG is given by the ith column of IQ1R 85. IQ1R was calculated using stabilized bi-conjugate gradient (bicgstab) iterative scheme in Matlab R2018b®. The bicgstab converged usually within 5 to 7 iterations.

Time varying conditional probability of finding a node being active

The conditional probability of a node, such as NFκB, being updated to or maintained in an active state in a cell with a certain start state v®0 having to ability to reach both apoptosis and pro-survival attractors is governed by the multiple signal flow paths from v®0. These signal flow paths may overlap. All signal flow paths from v®0 are first identified (Methods). Intermediate states in these signal flow paths are aligned according to the update steps. Distinct states appearing in every update step across these signal flow paths are captured in an associated tmax×2N connectivity matrix (C), where tmax is that maximum pseudo-time step by when all signal flow paths from v®0 have reached a fixed point or a set of states that recur thereafter. Note that the states in this recurring set are either (i) in the strongly connected component (SCC) or (ii) in any of the paths between the states in SCC and a FP or (iii) FPs themselves. The elements of the first and subsequent (tth timestep) rows of C are respectively captured by

C1j=1,ifMv¯0j00,otherwise 8

and

Ctj=1,ifiMijC(t1)i0inthetthupdatestep0,otherwise 9

For the TNFR1 network (Fig. 2), tmax=12. (Procedure for finding tmax is in Supplementary Note 4.8). In the tth update step, the overall transition probability of different one-step transitions resulting in a state j (with NFκB updated to or maintained in an active state) in these signal flow paths are captured in a tmax×2N signal-flow-path matrix P. The elements in the first and subsequent rows of P are respectively specified as

P1j=Mv¯0j|(vNFκB=1inj)j=1,2N 10

and

Ptj=i=12NMijC(t1)i(vNFκB=1inj)j=1,2N 11

For a start state v®0, the timestep dependent conditional probability ENFκBtv®0 that NFκB is active at the tth timestep is the overall fraction of one-step transitions at step t leading to NFκB either transitioning to active form or being maintained at “1”. This conditional probability for the first and tth timestep, respectively, are given by

ENFκB1v®0=j=12NP1j 12

and

ENFκBtv¯0=j=12NPtjj=12NC(t1)j 13

ENFκB1v®0 (Eqs. 12 and 13) specifies the NFκB transients for a given start state in the BD modeling framework. Such transients estimated for all possible start states in the STG collectively gives the ensemble-level dynamics similar to that obtained from experimental measurements. This procedure was used to estimate the ensemble-level dynamics of PI3K and c3*p17 nodes in the TNFR1 network (Fig. 2).

Inhibition of TAK1

Takinib (EDHS-206)69 (MedChemExpress) was dissolved in DMSO to a concentration of 10 mM and the stock was stored at −20°C until use. Cells were pre-treated with 20μM Takinib, which inhibits the activity of TAK1, for 1 hr before stimulating with 100 ng/ml TNFα. As a control case for this, cells were treated only with Takinib for a prolonged duration, details of which are in Supplementary Note 4.7.

Reporting summary

Further information on research design is available in the Nature Research Reporting Summary linked to this article.

Supplementary information

Reporting Summary (670.9KB, pdf)

Acknowledgements

This study was funded by the grants CRG/2020/002672 (GAV) and MTR/2020/000589 (GAV) from Science and Engineering Research Board, Department of Science and Technology, Government of India. SS is funded by Department of Biotechnology Junior Research Fellowship (DBT/2017/IIT-B/852). CST is funded by Prime Minister Research Fellowship (PMRF 1302047). We gratefully acknowledge an access to the C-DAC Supercomputing Facility and the FACS Central facility, IIT Bombay.

Author contributions

S.S. and G.A.V. conceptualized the study and analyzed the data. S.S. developed the methodology, designed codes, performed simulations, curated data, and prepared the initial draft of the manuscript including figures. C.S.T. contributed to methodology, conducted experiments, analyzed data and prepared a part of the initial draft of the manuscript including figures. G.A.V. supervised and administered the project, acquired the financial support for the study, contributed to the methodology, provided resources and wrote the manuscript. All authors read and approved the final manuscript.

Data availability

All data used in this study are available within the manuscript and the associated Supplementary Information files.

Code availability

The codes are written in Matlab and are available via GitHub at https://github.com/ganeshIITB/BMProSPR.git.

Competing interests

The authors declare no competing interests.

Footnotes

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Change history

1/19/2024

A Correction to this paper has been published: 10.1038/s41540-024-00338-4

Supplementary information

The online version contains supplementary material available at 10.1038/s41540-023-00318-0.

References

  • 1.Wajant H, Pfizenmaier K, Scheurich P. Tumor necrosis factor signaling. Cell Death Differ. 2003;10:45–65. doi: 10.1038/sj.cdd.4401189. [DOI] [PubMed] [Google Scholar]
  • 2.Wang X, Lin Y. Tumor necrosis factor and cancer, buddies or foes? Acta Pharmacol. Sin. 2008;29:1288. doi: 10.1111/j.1745-7254.2008.00889.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Gough P, Myles IA. Tumor necrosis factor receptors: pleiotropic signaling complexes and their differential effects. Front. Immunol. 2020;11:585880. doi: 10.3389/fimmu.2020.585880. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144:646–674. doi: 10.1016/j.cell.2011.02.013. [DOI] [PubMed] [Google Scholar]
  • 5.Ichim G, Tait SW. A fate worse than death: apoptosis as an oncogenic process. Nat. Rev. Cancer. 2016;16:539–548. doi: 10.1038/nrc.2016.58. [DOI] [PubMed] [Google Scholar]
  • 6.Chonghaile TN, et al. Pretreatment mitochondrial priming correlates with clinical response to cytotoxic chemotherapy. Science. 2011;334:1129–1133. doi: 10.1126/science.1206727. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Montero J, et al. Drug‐induced death signaling strategy rapidly predicts cancer response to chemotherapy. Cell. 2015;160:977–989. doi: 10.1016/j.cell.2015.01.042. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Biswas S, Tikader B, Kar S, Viswanathan GA. Modulation of signaling cross-talk between pJNK and pAKT generates optimal apoptotic response. PLOS Comput. Biol. 2022;18:e1010626. doi: 10.1371/journal.pcbi.1010626. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Manna SK, Aggarwal BB. Vesnarinone suppresses TNF-induced activation of NF-κB, c-Jun kinase, and apoptosis. J. Immunol. 2000;164:5815–5825. doi: 10.4049/jimmunol.164.11.5815. [DOI] [PubMed] [Google Scholar]
  • 10.Cho KH, Shin SY, Kolch W, Wolfkanheur O. Experimental design in systems biology, based on parameter sensitivity analysis using a monte carlo method: a case study for the tnfα-mediated nf-κb signal transduction pathway. Simulation. 2003;79:726–739. doi: 10.1177/0037549703040943. [DOI] [Google Scholar]
  • 11.Schlatter R, et al. Modeling the TNFα induced apoptosis pathway in hepatocytes. PLoS One. 2011;6:e18646. doi: 10.1371/journal.pone.0018646. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Schmich K, et al. Tumor necrosis factor α sensitizes primarymurine hepatocytes to Fas/CD95 induced apoptosis in a Bim- and Bid- dependent manner , Hepatology. 2011;53:282–291. doi: 10.1002/hep.23987. [DOI] [PubMed] [Google Scholar]
  • 13.Hayden MS, Ghosh S. Signaling to NF-κB. Genes Dev. 2004;18:2195–2224. doi: 10.1101/gad.1228704. [DOI] [PubMed] [Google Scholar]
  • 14.de Moissac D, Mustapha S, Greenberg AH, Kirshenbaum LA. Bcl-2 activates the transcription factor NFkappaB through the degradation of the cytoplasmic inhibitor IkappaBalpha. J. Biol. Chem. 1998;273:23946–23951. doi: 10.1074/jbc.273.37.23946. [DOI] [PubMed] [Google Scholar]
  • 15.Oliver Metzig M, et al. An incoherent feedforward loop interprets NFκB/RelA dynamics to determine TNF‐induced necroptosis decisions. Mol. Syst. Biol. 2020;16:e9677. doi: 10.15252/msb.20209677. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Osawa Y, et al. TNF-α-induced sphingosine 1-phosphate inhibits apoptosis through a phosphatidylinositol 3-kinase/Akt pathway in human hepatocytes. J. Immunol. 2001;167:173–180. doi: 10.4049/jimmunol.167.1.173. [DOI] [PubMed] [Google Scholar]
  • 17.Rangamani P, Sirovich L. Survival and apoptotic pathway initiated by TNFα: modeling and predictions. Biotechnol. Bioeng. 2007;97:1216–1229. doi: 10.1002/bit.21307. [DOI] [PubMed] [Google Scholar]
  • 18.Wang CY, Mayo MW, Korneluk RG, Goeddel DV, Baldwin AS., Jr NF-κB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation. Science. 1998;281:1680–1683. doi: 10.1126/science.281.5383.1680. [DOI] [PubMed] [Google Scholar]
  • 19.Stehlik C, et al. Nuclear factor (NF)-κB–regulated X-chromosome–linked iap gene expression protects endothelial cells from tumor necrosis factor α–induced apoptosis. J. Exp. Med. 1998;188:211–216. doi: 10.1084/jem.188.1.211. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Fumia HF, Martins ML. Boolean network model for cancer pathways predicting carcinogenesis and targeted therapy outcomes. PLoS One. 2013;8:e69008. doi: 10.1371/journal.pone.0069008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Koh G, Lee DY. Mathematical modeling and sensitivity analysis of the integrated TNFα mediated apoptotic pathway for identify key regulators. Comput. Biol. Med. 2011;41:512–528. doi: 10.1016/j.compbiomed.2011.04.017. [DOI] [PubMed] [Google Scholar]
  • 22.Lavrik IN. Systems Biology of Apoptosis. Springer, New York (2013)
  • 23.Hsu H, Xiong J, Goeddel DV. The TNF receptor 1-associated protein TRADD signals cell death and NF-κB activation. Cell. 1995;81:495–504. doi: 10.1016/0092-8674(95)90070-5. [DOI] [PubMed] [Google Scholar]
  • 24.Wajant H, Scheurich P. TNFR1‐induced activation of the classical NF‐κB pathway. FEBS J. 2011;278:862–876. doi: 10.1111/j.1742-4658.2011.08015.x. [DOI] [PubMed] [Google Scholar]
  • 25.Amstein LK, et al. Mathematical modeling of the molecular switch of TNFR1-mediated signaling pathways applying Petri net formalism and in silico knockout analysis. PLOS Comput. Biol. 2022;18:e1010383. doi: 10.1371/journal.pcbi.1010383. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Karin Michael, Delhase Mireille. The IκB kinase (IKK) and NF-κB: key elements of proinflammatory signaling. Semin. Immunol. 2000;12:85–98. doi: 10.1006/smim.2000.0210. [DOI] [PubMed] [Google Scholar]
  • 27.Michieu O. Tshopp. Induction of TNF receptor-I mediated apoptosis via two sequential ssignaling complexes. Cell. 2003;114:181–190. doi: 10.1016/S0092-8674(03)00521-X. [DOI] [PubMed] [Google Scholar]
  • 28.Calzolari D, Paternostro G, Harrington PL, Jr, Piermarocchi C, Duxbury PM. Selective control of apoptosis signaling network in heterogenous cell population. PLoS One. 2007;2:e547. doi: 10.1371/journal.pone.0000547. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Buchbinder JH, Pischel D, Sundmacher K, Flassig RJ, Lavrik IN. Quantitative single cell analysis uncovers the life/death decision in CD95 network. PLoS Comput. Biol. 2018;14:e1006368. doi: 10.1371/journal.pcbi.1006368. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Yachie‐Kinoshita A, et al. Modeling signaling‐dependent pluripotency with Boolean logic to predict cell fate transitions. Mol. Syst. Biol. 2018;14:e7952. doi: 10.15252/msb.20177952. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Matveeva A, et al. Heterogeneous responses to low level death receptor activation are explained by random molecular assembly of the Caspase-8 activation platform. PLoS Comput. Biol. 2019;15:e1007374. doi: 10.1371/journal.pcbi.1007374. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Spencer SL, Gaudet S, Albeck JG, Burke JM, Sorger PK. Non-genetic origins of cell-to-cell variability in TRAIL-induced apoptosis. Nature. 2009;459:428–432. doi: 10.1038/nature08012. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Xia X, Owen MS, Lee REC, Gaudet S. Cell-to-cell variability in cell death: can systems biology help us make sense of it all? Cell Death Dis. 2014;5:e1261. doi: 10.1038/cddis.2014.199. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Inde Z, Forcina GC, Denton K, Dixon SJ. Kinetic heterogeneity of cancer cell fractional killing. Cell Rep. 2020;32:107845. doi: 10.1016/j.celrep.2020.107845. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Rhee A, Cheong R, Levchenko A. Noise decomposition of intracellular biochemical signaling networks using nonequivalent reporters. Proc. Natl Acad. Sci. 2014;111:17330–17335. doi: 10.1073/pnas.1411932111. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Kitano H. Cancer as a robust system: implications for anticancer therapy. Nat. Rev. Cancer. 2004;4:227–235. doi: 10.1038/nrc1300. [DOI] [PubMed] [Google Scholar]
  • 37.Saadatpour A, Albert I, Albert R. Attractor analysis of asynchronous Boolean models of signal transduction networks. J. Theor. Biol. 2010;266:641–656. doi: 10.1016/j.jtbi.2010.07.022. [DOI] [PubMed] [Google Scholar]
  • 38.Schlatter R, et al. On/ off and beyond–a Boolean model of apoptosis. PLoS Comput. Biol. 2009;5:e1000595. doi: 10.1371/journal.pcbi.1000595. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Madrahimov A, Helikar T, Kowal B, Lu G, Rogers J. Dynamics of influenza virus and human host interactions during infection and replication cycle. Bull. Math. Biol. 2013;75:988–1011. doi: 10.1007/s11538-012-9777-2. [DOI] [PubMed] [Google Scholar]
  • 40.Saadatpour A, Albert R. Boolean modeling of biological regulatory networks: A methodology tutorial. Methods. 2013;62:3–12. doi: 10.1016/j.ymeth.2012.10.012. [DOI] [PubMed] [Google Scholar]
  • 41.Calzone L, et al. Mathematical modeling of cell-fate decision in response to death receptor engagement. PLOS Comput. Biol. 2010;6:e1000702. doi: 10.1371/journal.pcbi.1000702. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Saadatpour A, et al. Dynamical and structural analysis of a T-cell survival network identifies novel candidate therapeutic targets for large granular lymphocyte leukemia. PLOS Comput. Biol. 2011;7:e1002267. doi: 10.1371/journal.pcbi.1002267. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Steinway SN, et al. Network modeling of TGFβ signaling in hepatocellular carcinoma epithelial-to-mesenchymal transition reveals joint sonic hedgehog and Wnt pathway activation. Cancer Res. 2014;74:5963–5977. doi: 10.1158/0008-5472.CAN-14-0225. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Manicka S, Johnson K, Levin M, Murrugarra D. The nonlinearity of regulation in biological networks. npj Syst. Biol. Appl. 2023;9:10. doi: 10.1038/s41540-023-00273-w. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Chang R, Shoemaker R, Wang W. Systematic search for recipes to generate induced pluripotent stem cells. PLoS Comput. Biol. 2011;7:e1002300. doi: 10.1371/journal.pcbi.1002300. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Geng J, et al. Regulation of RIPK1 activation by TAK1-mediated phosphorylation dictates apoptosis and necroptosis. Nat. Commun. 2017;8:359. doi: 10.1038/s41467-017-00406-w. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Tremblay MJ, Angel JB, Kumar A. Role of RIPK1 in SMAC mimetics-induced apoptosis in primary human HIV-infected macrophages. Sci. Rep. 2021;11:22901. doi: 10.1038/s41598-021-02146-w. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Holbrook J, Lara-Reyna S, Jarosz-Griffiths H, McDermott MF. Tumour necrosis factor signaling in health and disease. F1000Research. 2019;8:111. doi: 10.12688/f1000research.17023.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Nagata S. Fas ligand induced apoptosis. Ann. Rev. Genet. 1999;33:29–55. doi: 10.1146/annurev.genet.33.1.29. [DOI] [PubMed] [Google Scholar]
  • 50.Klamt S, Rodriguez JS, Gilles ED. Structural and functional analysis of cellular networks with CellNetAnalyzer. BMC Syst. Biol. 2007;1:1–13. doi: 10.1186/1752-0509-1-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Sherekar S, Viswanathan GA. Boolean dynamic modeling of cancer signaling networks: prognosis, progression, and therapeutics. Comput. Syst. Oncol. 2021;1:e1017. doi: 10.1002/cso2.1017. [DOI] [Google Scholar]
  • 52.Udyavar AR, et al. Novel hybrid phenotype revealed in small cell lung cancer by a transcription factor network model that can explain tumor heterogeneity. Cancer Res. 2017;77:1063–1074. doi: 10.1158/0008-5472.CAN-16-1467. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Holme P, Saramaki J. Temporal networks. Phys. Rep. 2012;519:97–125. doi: 10.1016/j.physrep.2012.03.001. [DOI] [Google Scholar]
  • 54.Tang D, et al. Predictability of real temporal networks. Nat. Sci. Rev. 2020;7:929–937. doi: 10.1093/nsr/nwaa015. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55.Li A, et al. Evolution for cooperation on temporal networks. Nat. Comm. 2020;11:2268. doi: 10.1038/s41467-020-16088-w. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56.Haveliwala TH. Topic sensitive PageRank: A context-sensitive ranking algorithm for web search. IEEE Trans. Knowl. Data Eng. 2003;15:784–796. doi: 10.1109/TKDE.2003.1208999. [DOI] [Google Scholar]
  • 57.Gliech DF, Gray AP, Greif C, Lau T. An inner-outer iteration for computing PageRank. SIAM J. Sci. Comp. 2010;32:371. [Google Scholar]
  • 58.Gliech DF. PageRank beyond the web. SIAM Rev. 2015;57:321–363. doi: 10.1137/140976649. [DOI] [Google Scholar]
  • 59.Sen PK. Estimates of the regression coefficient based on Kendall’s tau. J. Am. Stat. Assoc. 1968;63:1379–1389. doi: 10.1080/01621459.1968.10480934. [DOI] [Google Scholar]
  • 60.Baeza-Yates R, Boldi P, Castillo C. Generalizing PageRank: Damping functions for link-based ranking algorithms. InProc. of the 29thannual international ACM SIGIR conference on Research and development in information retrieval, 308–315 (2006)
  • 61.Lovrics A, et al. Boolean modeling reveals new regulatory connections betwee transcription factors orchestrating the development of the Ventral spinal cord. PLoS One. 2014;9:e111430. doi: 10.1371/journal.pone.0111430. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 62.Oeckinghaus A, Ghosh S. The NF-κB family of transcription factors and its regulation. Cold Spring Harbor Perspect. Biol. 2009;1:a000034. doi: 10.1101/cshperspect.a000034. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 63.Hoffmann A, Levchenko A, Scott ML, Baltimore D. The IκB-NF-κB signaling module: temporal control and selective gene activation. Science. 2002;298:1241–1245. doi: 10.1126/science.1071914. [DOI] [PubMed] [Google Scholar]
  • 64.Madrid LV, et al. Akt suppresses apoptosis by stimulating the transactivation potential of the ReIA/p65 subunit of NFκB. Mol. Cell. Biol. 2000;20:1626–1638. doi: 10.1128/MCB.20.5.1626-1638.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 65.Arsura M, Mercurio F, Oliver AL. Role of the IκB kinase complex in oncogenic Ras- and Raf- mediated transformation of rat liver epithelial cell. Mo. Cell. Biol. 2000;20:5381–5391. doi: 10.1128/MCB.20.15.5381-5391.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 66.Lin G, Tang Z, Ye YB, Chen Q. NFκB activity is downregulated by KRAS knockdown in SW620 cells via Ras-ERK-IκBα pathway. Oncol. Rep. 2012;27:1527–1534. doi: 10.3892/or.2012.1669. [DOI] [PubMed] [Google Scholar]
  • 67.Devalaraj MN, Wang DZ, Ballard DW, Richmond A. Elevated constitutive IkappaB kinase activity and IkappaB-alpha phosphorylation in Hs294T melanoma cells lead to increased basal MGSA/GRO-alpha transcription. Cancer Res. 1999;59:1372–1377. [PubMed] [Google Scholar]
  • 68.Rayet B, Gelinas C. Aberrant rel/nfkb genes and activity in human cancer. Oncogene. 1999;18:6938–6947. doi: 10.1038/sj.onc.1203221. [DOI] [PubMed] [Google Scholar]
  • 69.Totzke J, et al. Takinib, a selective TAK1 inhibitor, broadens the therapeutic efficacy of TNF-α inhibition for cancer and autoimmune disease. Cell Chem. Biol. 2017;24:1029–1039. doi: 10.1016/j.chembiol.2017.07.011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 70.Dondelinger Y, et al. NF-κB-independent role of IKKα/IKKβ in preventing RIPK1 kinase-dependent apoptotic and necroptotic cell death during TNF signaling. Mol. Cell. 2015;60:63–76. doi: 10.1016/j.molcel.2015.07.032. [DOI] [PubMed] [Google Scholar]
  • 71.Karin M, Delhase M. The I kappa B kinase (IKK) and NF-kappa B: key elements of proinflammatory signaling. Semin. Immunol. 2000;12:85–98. doi: 10.1006/smim.2000.0210. [DOI] [PubMed] [Google Scholar]
  • 72.Buglio D, et al. Essential role of TAK1 in regulating mantle cell lymphoma survival. Blood. 2012;120:347–355. doi: 10.1182/blood-2011-07-369397. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 73.Deveraux QL, et al. IAPs block apoptotic events induced by caspase-8 and cytochrome c by direct inhibition of distinct caspases. EMBO J. 1998;17:2215–2223. doi: 10.1093/emboj/17.8.2215. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 74.Sadeghi Rad H, et al. Understanding the tumor microenvironment for effective immunotherapy. Med. Res. Rev. 2021;41:1474–1498. doi: 10.1002/med.21765. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 75.Berraondo P, et al. Cytokines in clinical cancer immunotherapy. Br. J. Cancer. 2019;120:6–15. doi: 10.1038/s41416-018-0328-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 76.Jang DI, et al. The role of tumor necrosis factor alpha (TNF-α) in autoimmune disease and current TNF-α inhibitors in therapeutics. Int. J. Mol. Sci. 2021;22:2719. doi: 10.3390/ijms22052719. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 77.Menon MB, et al. p38MAPK/MK2-dependent phosphorylation controls cytotoxic RIPK1 signaling in inflammation and infection. Nat. Cell Biol. 2017;19:1248–1259. doi: 10.1038/ncb3614. [DOI] [PubMed] [Google Scholar]
  • 78.Dondelinger Y, et al. MK2 phosphorylation of RIPK1 regulates TNF-mediated cell death. Nat. Cell Biol. 2017;19:1237–1247. doi: 10.1038/ncb3608. [DOI] [PubMed] [Google Scholar]
  • 79.Wertz IE. TNFR1-activated NFkB signal transduction: Regulation by the ubiquitin/proteasome system. Curr. Opin. Chem. Biol. 2014;23:71–77. doi: 10.1016/j.cbpa.2014.10.011. [DOI] [PubMed] [Google Scholar]
  • 80.Ea CK, Deng L, Xia ZP, Pineda G, Chen ZJ. Activation of IKK by TNFα requires site-specific ubiquitination of RIP1 and polyubiquitin binding by NEMO. Mol. Cell. 2006;22:245–57. doi: 10.1016/j.molcel.2006.03.026. [DOI] [PubMed] [Google Scholar]
  • 81.Fujita H, et al. Mechanism underlying IκB kinase activation mediated by the linear ubiquitin chain assembly complex. Mol. Cell. Biol. 2014;34:1322–1335. doi: 10.1128/MCB.01538-13. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 82.Katsuya K, et al. Small molecule inhibitors of linear ubiquitin chain assembly complex (LUBAC), HOIPINs suppress NFκB signaling. Biochem. Biophys. Res. Comm. 2019;509:700–706. doi: 10.1016/j.bbrc.2018.12.164. [DOI] [PubMed] [Google Scholar]
  • 83.Zañudo JG, Steinway SN, Albert R. Discrete dynamic network modeling of oncogenic signaling: Mechanistic insights for personalized treatment of cancer. Curr. Opin. Syst. Biol. 2018;9:1–10. doi: 10.1016/j.coisb.2018.02.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 84.https://docs.scipy.org/doc/scipy/reference/generated/scipy.stats.kendalltau.html
  • 85.Grinstead CM, Snell JL. Introduction to probability, 2ndEd. AMS Providence (2009)

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Reporting Summary (670.9KB, pdf)

Data Availability Statement

All data used in this study are available within the manuscript and the associated Supplementary Information files.

The codes are written in Matlab and are available via GitHub at https://github.com/ganeshIITB/BMProSPR.git.


Articles from NPJ Systems Biology and Applications are provided here courtesy of Nature Publishing Group

RESOURCES